Drug Patent Watch
FEBRUARY 2, 2021
DrugPatentWatch was featured in a recent article by Inc. In their coverage of Mark Cuban’s new pharma company, they cited our published interview where Mark Cuban Sounds off on Drug Prices.…. The post DrugPatentWatch featured in Inc Magazine appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
JULY 25, 2023
In a recent article published by IAM Magazine, titled “Why Pharma Companies Should File Patents Later In The R&D Process,” Alexander R. Trimble, PhD, a prominent patent attorney, explores the… The post Filing Strategies for Maximizing Pharma Patents appeared first on DrugPatentWatch - Make Better Decisions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Target Review
DECEMBER 20, 2024
Smith states, weve definitely come across people in the pharma industry who worry that AI means companies might steal our data or use it in harmful ways. As the industry gains more exposure to AIs real-world applications and the rigorous standards AI companies adhere to, trust will continue to grow.
Vial
FEBRUARY 15, 2024
This article discusses current challenges in managing clinical trials and elucidates the pivotal role that CROs play in overcoming these obstacles. According to the 2022 Polaris Market Research Report , the global clinical trials outsourcing market reached USD 38.11 over the forecast period (2022-2030).
Drug Target Review
SEPTEMBER 5, 2024
However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company. All types of activities encouraging women in STEM is important, like this article.
Reprocell
NOVEMBER 1, 2022
Pharma companies are legally required to test novel drugs in animal models before beginning human trials. An article published in the Financial Times described how scientists are moving away from animal experimentation toward alternatives that more closely resemble human physiology.
Eye on FDA
JANUARY 9, 2022
None of the studies underway are aimed at uncovering data that would be helpful in providing additional guidance related to the use of digital and social platforms by patients, prescribers and pharma companies. Why This is a Fail. People do still watch commercial television, but in fewer and fewer numbers.
Expert insights. Personalized for you.
103 
Let's personalize your content